Symmetrical—lesions appear to be distributed in a similar arrangement on differing sides of the body (Figure 3, see slideshow) Once the configuration and distribution has been determined, the next ...

Self-examination behavior varied markedly: roughly 20% reported none in the prior year, while about one-third examined weekly or monthly despite >90% rating checks as important. Nearly half of trial ...

The Food and Drug Administration has authorized the first artificial intelligence-powered medical device to help doctors detect the most common forms of skin cancer in patients. The technology, from ...

New data from the MEL-SELF trial show gaps in melanoma self-surveillance confidence, highlighting opportunities to improve early detection.

Artificial intelligence (AI) programs have recently acquired widespread popularity in dermatology for assessing, diagnosing, and treating skin conditions. As reported in the International Journal of ...

Please provide your email address to receive an email when new articles are posted on . The device is a handheld tool that uses spectroscopy and algorithms to test worrisome skin lesions for cancer.

In January, after the DermaSensor became the first artificial intelligence (AI)-enabled device cleared by the US Food and Drug Administration (FDA) to evaluate lesions suggestive of skin cancer, the ...

Using cutting-edge bioinformatics techniques for gene identification and sequencing, researchers are comprehensively mapping signaling pathway distributions in both normal and acne-affected skin. Acne ...

Atrophy: Atrophy is a skin depression resulting from thinned epidermis and/or dermis. Topical-steroid-induced striae (striae distensae). These marks are a dose-, vehicle-, time-, and ...